Clinical Education InitiativeMenu
Search
Home > Courses > AIDS-defining CMV Retinitis & Colitis

AIDS-defining CMV Retinitis & Colitis

AIDS-defining CMV Retinitis & Colitis
Play
Sorry, this learning module is not available for mobile devices.
Original Presentation: 11/10/2015
Web Posting: 3/25/2016
CE Expiration: 11/09/2018
Presenters
  • Christopher T. Coad, MD
    Surgical Director of Eye Care
    Chelsea Eye & Cosmetic Surgery Associates, New York, NY
  • Donald P. Kotler, MD
    Professor of Medicine
    Columbia University College of Physicians and Surgeons
Learning Objectives
At the completion of this educational session, participants will:
  1. Recognize signs and symptoms of CMV retinitis.
  2. Appreciate the treatments for CMV retinitis.
  3. Be aware of the pathologic and physiologic changes in the gastrointestinal tract that resulted from cytomegalovirus infection in immune deficient people in the pre-HAART era.
  4. Understand changes that occurred as a result of antiviral treatment of CMV colitis.
Presenter Bios
Christopher Coad, MD
Chris Coad of Chelsea Eye & Cosmetic Surgery Associates is Board Certified by the American Board of Ophthalmology, is a fellow of the American College of Surgeons (F.A.C.S.). He is an attending physician at the New York Eye and Ear Infirmary and part of Continuum Health Partners. He continues to travel the world exchanging ophthalmic skills as a member of the ORBIS team and lectures on his areas of expertise including all laser iLASIK and advanced cataract surgery.
Donald Kotler, MD
Donald P. Kotler is a gastroenterologist, an expert on GI manifestations of HIV disease, and a pioneer in the study of the AIDS wasting syndrome. Dr. Kotler has concentrated on the study of body composition in order to define the characteristics of malnutrition in HIV infection and other diseases, as well as strategies to reverse the wasting process. He has been the Principal investigator on single-site and multi-center studies of nutritional therapies for HIV-associated malnutrition. In addition, Dr. Kotler has studied the opportunistic enteric complications of AIDS as well as the role of HIV as an enteric pathogen. More recently, he has studied the body composition and metabolic abnormalities associated with lipodystrophy, and is applying his knowledge and laboratory techniques to the study of chronic liver disease. 
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on November 10, 2015 and will terminate November 9, 2018.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Coad (Presenter) had no relevant financial relationships to disclose. Dr. Coad submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
  • Dr. Kotler (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Advisor honorarium from Gilead. Dr. Kotler submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules